Supply Chain News

Machine Learning Supports Effective Antibiotic Discovery

by

With the prevalence of antibiotic resistance rapidly rising, a new study published in Cell is offering a more efficient, cost-efficient strategy for antibiotic discovery using machine learning. There...

International Reference Pricing Implementation Challenges

by

Tying drug prices to those in other developed countries may be a useful strategy for lowering US prescription drug spending, but international reference pricing may not be ideal, according to...

FDA, Indian Government Stop 500 Illicit Prescription Drug Shipments

by

The FDA announced that Operation Broadsword, its enforcement operation with the Government of India, stopped nearly 500 shipments of illicit prescription drugs and medical devices from reaching...

Prescription Drug Prices Rose 21% as Utilization Remained Steady

by

Prescription drug prices continue to increase due to continued growth in medical service costs and a modest uptick in utilization, according to a recent report from the Health Care Cost Institute...

Pharmaceutical Company Mallinckrodt Sued Over Seizure Drug Cost

by

The city of Marietta has filed a class action lawsuit against drug manufacturer Mallinckrodt, claiming the company increased the price for a specific seizure medication by 97,500 percent, according to...

GoodRx Names Top 20 Most Expensive Prescription Drugs in 2020

by

According to a GoodRx analysis, Myalept is the most expensive prescription drug in the US in 2020 with a list price of $72,306.  In their yearly analysis, GoodRx researchers broke down the most...

Biogen Triumphs Over Patent Challenge of Multiple Sclerosis Drug

by

Biogen recently won an ongoing patent dispute over its multiple sclerosis (MS) drug, Tecfidera, which pulled in nearly $4.4 billion in revenue in 2019, according to a decision from the US Patient and...

White House Releases Drug Control Strategy for 2020

by

The White House Office of National Drug Control Policy released updates to the Trump administration’s national drug control strategy on Monday to address drug abuse and misuse.  The 44-page...

FDA, FTC Join Forces on Biologics Competition

by

The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) on Monday issued a set of four joint goals to support a competitive US marketplace for approved biological products,...

USMCA Approval Signals Drug Pricing Changes Ahead

by

The Senate’s January 16 approval of the US-Mexico-Canada (USMCA) Agreement was well-received by industry groups who argued for it to serve as a template for ongoing trade deal negotiations to...

GAO Flags Lack of 340B Drug Discount Program Oversight

by

Weakness in the oversight of the 340B Drug Discount Program allowed some hospitals to get discounted drugs they were ineligible for, a Government Accountability Office analysis found.  Hospitals,...

USMCA Makes its Way to Full Senate Vote After Lobbying Win

by

The Senate Finance Committee passed the US-Mexico-Canada (USMCA) Trade Agreement of 2019 on Tuesday, in a 25-3 vote. Other senate committees are now are set to debate the trade agreement, beginning...

Oncologists Influence Peers in Prescribing Novel Therapies

by

A new study finds that leveraging physician ties can promote targeted adoption of high-value therapies. As part of the longitudinal study published in JAMA, researchers constructed physician networks...

Implications of Value-Based Contracting for Drug Companies

by

Industry experts have come to agree that the traditional method for financing the healthcare system is not working. National healthcare expenditures are accelerating at an unsustainable rate, with...

Role of Pharmacy Benefit Managers in the Pharmaceutical Supply Chain

by

As the healthcare industry works to tackle skyrocketing spending, a keen eye is turning toward the pharmaceutical industry. And with that, experts are examining the role pharmacy benefits managers play...

Pharmaceutical Marketing Strategies Targeting Medication Adherence

by

Medication adherence is essential to effective chronic disease management. But as healthcare industry experts see adherence rates flounder, it must look to targeted pharmaceutical marketing...